Pharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of Samples
Khokhlov, A. L., Grebenkin, D. Yu, Faeva, E. K., Kazey, V. I., Khokhlov, A. A., Miroshnikov, A. E., Lebedeva, O. V.
Published in Razrabotka i registraciâ lekarstvennyh sredstv (Online) (28.02.2023)
Published in Razrabotka i registraciâ lekarstvennyh sredstv (Online) (28.02.2023)
Get full text
Journal Article
Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva
Published in Фармакокинетика и Фармакодинамика (01.05.2022)
Published in Фармакокинетика и Фармакодинамика (01.05.2022)
Get full text
Journal Article